A Study to Assess the Safety of Single Doses of GSK189075 in Subjects With Type 1 Diabetes Mellitus

Launched by GLAXOSMITHKLINE · Dec 14, 2007

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult male/female, 18 to 55 years old
• • Diagnosis of type 1 diabetes mellitus for at least 6 months; and using a continuous insulin pump
• • Willing and able to follow all study-related instructions provided by the site staff.
• • Willing to provide signed informed consent.
• Exclusion Criteria:
• • Pregnant or a nursing female.
• • Have a past or current disease such as heart, liver, kidney, blood, brain, or other disease.
• • Have HIV or hepatitis, or have alcohol or drugs in your system at the screening visit.
• • Have a history of alcohol abuse or have an eating disorder
• • Have been in another research study in the last month or have taken certain medications in the 1 week before study drug would be taken.